TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17

Oncology Reports

Volumn 25, Issue 5, 2011, Pages 1329-1335

  Lu, Yong ^a,b   Jiang, Feng ^b   Zheng, Xuguang ^b   Katakowski, Mark ^b   Buller, Benjamin ^b   To, Shing Shun Tony ^a   Chopp, Michael ^b,c  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b HENRY FORD HOSPITAL   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

ADAM17; Glioma; Invasion; Migration; Transforming growth factor 1

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; MESSENGER RNA; TAPI 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR PROMOTION; UPREGULATION;

ADAM PROTEINS; BENZAMIDES; CELL LINE, TUMOR; CELL MOVEMENT; DIOXOLES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79953045754     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1195     Document Type: Article

References (34)

1. Lampert K, Machein U, Machein MR, Conca W, Peter HH and Volk B: Expression of matrix metalloproteinases and their tissue inhibitors inhuman brain tumors. Am J Pathol 153: 429-437, 1998. (Pubitemid 28373654)
2. Nakano A, Tani E, Miyazaki K, Yamamoto Y and Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995.
3. Siegel PM and Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3: 807-821, 2003.
4. Akhurst RJ and Derynck R: TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 11: S44-S51, 2001.
5. Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001. (Pubitemid 32952643)
6. Hau P, Kunz-Schughart LA, Rummele P, et al: Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. J Neurooncol 77: 1-7, 2006. (Pubitemid 43870555)
7. McEarchern JA, Kobie JJ, Mack V, et al: Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer 91: 76-82, 2001.
8. Fu H, Hu Z, Wen J, Wang K and Liu Y: TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascinl expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai) 41: 648-656, 2009.
9. Muraoka-Cook RS, Shin I, Yi JY, et al: Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene 25: 3408-3423, 2006. (Pubitemid 43877044)
10. Leivonen SK and Kahari VM: Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 121: 2119-2124, 2007.
11. Platten M, Wick W Wild-Bode C, Aulwurm S, Dichgans J and Weller M: Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via up -regulation of alpha(V)beta(3) integrin expression. Biochem Biophys Res Commun 268: 607-611, 2000.
12. Stiles JD, Ostrow PT, Balos LL, et al: Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol 56: 435-439, 1997. (Pubitemid 27465026)
13. Platten M, Wick W and Weller M: Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52: 401-410, 2001. (Pubitemid 32167828)
14. Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J and Weiler M: N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells. Int J Cancer 93: 53-61, 2001.
15. Arslan F, Bosserhoff AK, Nicki-Jockschat T, Doerfelt A, Bogdahn U and Hau P: The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-beta2. Br J Cancer 96: 1560-1568, 2007. (Pubitemid 46762960)
16. Mirake K, Kimura S, Nakanishi M, et al: Transforming growth factor-betal stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression. J Neuropathol Exp Neurol 59: 18-28, 2000. (Pubitemid 30069222)
17. Bhowmick NA, Ghiassi M, Bakin A, et al: Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12: 27-36, 2001. (Pubitemid 32060576)
18. Jachimczak P, Hessdorfer B, Fabel-Schulte K, et al: Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides. Int J Cancer 65: 332-337, 1996. (Pubitemid 26059987)
19. Horst HA, Scheithauer BW, Kelly PJ and Kovach JS: Distribution of transforming growth factor-beta 1 in human astrocytomas. Hum Pathol 23: 1284-1288, 1992.
20. Schneider T, Sailer M, Ansorge S, Firsching R and Reinhold D: Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma. J Neurooncol 79: 61-65, 2006. (Pubitemid 44057419)
21. Samuels V, Barrett JM, Bockman S, Pantazis CG and Allen MB Jr: Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134: 894-902, 1989.
22. Kjellman C, Olofsson SP, Hansson O, et al: Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer 89: 251-258, 2000. (Pubitemid 30430741)
23. Paulus W, Baur I, Huettner C, et al: Effects of transforming growth factor-beta 1 on collagen synthesis, integrin expression, adhesion and invasion of glioma cells. J Neuropathol Exp Neurol 54: 236-244, 1995.
24. Lu X, Lu D, Scully M and Kakkar V: ADAM proteins-therapeutic potential in cancer. Curr Cancer Drug Targets 8: 720-732, 2008.
25. Kheradmand F and Werb Z: Shedding light on sheddases: role in growth and development. Bioessays 24: 8-12, 2002. (Pubitemid 34108414)
26. Kenny PA: TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation 75: 800-808, 2007.
27. Wildeboer D, Naus S, Amy Sang QX, Bartsch JW and Pagenstecher A: Metalloproteinase disintegrins ADAMS and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol 65: 516-527, 2006. (Pubitemid 44297273)
28. Zheng X, Jiang F, Katakowski M, et al: Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion. Cancer Lett 265: 177-187, 2008.
29. Zheng X, Jiang F, Katakowski M, et al: Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness. Cancer Sci 98: 674-684, 2007. (Pubitemid 46563443)
30. Tsatas D, Kanagasundaram V, Kaye A and Novak U: EGF receptor modifies cellular responses to hyaluronan in glioblastoma cell lines. J Clin Neurosci 9: 282-288, 2002.
31. Wang SE, Xiang B, Guix M, et al: Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in Erb B2-overexpressing breast cancer and desensitizes cells to trastuzumab. Mol Cell Biol 28: 5605-5620, 2008.
32. Wang SE, Xiang B, Zent R, Quaranta V, Pozzi A and Arteaga CL: Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res 69: 475-482, 2009.
33. Murillo MM, del Castillo G, Sanchez A, Fernandez M and Fabregat I: Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 24: 4580-4587, 2005. (Pubitemid 41032621)
34. Wesolowska A, Kwiatkowska A, Slomnicki L, et al: Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 27: 918-930, 2008. (Pubitemid 351225378)